A Study of LY3437943 in Chinese Participants With Obesity Or Overweight
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Eli Lilly and Company
Related studies linked through entity extraction aliases.
A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Donanemab (LY3002813) in Healthy Chinese Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis
- Status
- TERMINATED
- Phase
- PHASE2
A Bioequivalence Study of Mirikizumab (LY3074828) in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Imlunestrant (LY3484356) in Healthy Women
- Status
- COMPLETED
- Phase
- PHASE1
A Study of LY3484356 in Chinese Participants With Advanced Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Status
- RECRUITING
- Phase
- PHASE3
A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
ETHAN - ET for Male BC
- Status
- RECRUITING
- Phase
- PHASE2
177-Lutetium-PSMA Before Stereotactic Body Radiotherapy for the Treatment of Oligorecurrent Prostate Cancer, The LUNAR Study
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of LY3873862 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Clinical Trial of PR001 (LY3884961) in Patients With Peripheral Manifestations of Gaucher Disease (PROCEED)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study of LY3844583 in Healthy Participants and Participants With Atopic Dermatitis
- Status
- TERMINATED
- Phase
- PHASE1
A Drug Interaction Study of Clarithromycin and LY3502970 in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Effects of Selpercatinib (LY3527723) on Repaglinide in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Effect of Selpercatinib (LY3527723) in Participants With Normal and Impaired Renal Function
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Effect of Food and a Proton Pump Inhibitor on Selpercatinib (LY3527723) in Healthy Participants
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Insulin Efsitora Alfa (LY3209590) Compared With Insulin Degludec in Participants With Type 1 Diabetes Treated With Multiple Daily Injection Therapy
- Status
- COMPLETED
- Phase
- PHASE3